News About: Goverment
Multilateral appraisal system to apply for high government officials.
The MOHW is going to renovate the personnel management system reflected with its transparency, focusing it far on the objective and scientific standards, the enhanced transparency through an open process, the enhanced...
HIRA to regulate high-priced drugs
The Health Insurance Review Agency (HIRA) said at a meeting with parliamentary committee of health and welfare on April 21 that the agency will push to discourage the use of high-priced prescription drugs in the medic...
Relative benefit criteria for low-priced essential drugs questioned
Pharmaceutical business sources say that although the health ministry recently selected more 300 generics for cost compensation, the list of 400 essential drugs, which has selected by the government from April 2000, h...
KFDA to boost pharmaceutical export.
Before the end of this year 200 key export drug items will be selected under the incentive plans such as tax and other provisional benefits.
The KFDA took the lst meeting of the Pharmaceutical Export Supporting Ce...
Incentive plans for any drugs proven of its efficacy equivalency.
The KFDA will provide an incentive plan for any drugs that were already proved its efficacy equivalencies to the original products through not only the bio-equivalent test but also other physicochemical test or compar...
SARS tests needs to be clarified in parliamentary hearing
In line with the recent report of the National Institute of Health that is confusing the nation over the result of its tests on severe acute respiratory syndrome (SARS), Rep. Kim Hong-shin of the parliamentary committ...
MOHW not considers of Herbal Drug Administration Agency.
The MOHW decided not to establish the Herbal Drug Administration Agency, an independent organization demanded by the herbal medical community responsible for controlling the herbal drugs and herbal drug preparations s...
New Drug Review System to be revamped.
The KFDA plans to revamp the new drug review system by intensifying the pre-review controls and the obligation compliances through the working guideline revision. The KFDA has admitted the review system unnecessary an...
Drug-related administration to be ameliorated
Commissioner Shim Chang-koo of Korea Food and Drug Administration (KFDA) testified before a meeting of the Health and Welfare Committee of the National Assembly on April 14 that a series of measures will be adopted to...
NIH to change its name as "Disease Control Agency".
The MOHW said that the National Institute of Health (NIH) should be expanded and reorganized as to be more responsible for the prevention of the epidemic diseases like SARS , and therefore the institute could be chang...
